Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Elicio Therapeutics
company
About
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $3.30M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer. It offers potent vaccines and immunotherapies that enable precise targeting and delivery of immunogens directly to the lymphatic system, substantially enhancing the body's own system of immune defenses.The company was founded in 2011 and is based in Cambridge, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.30M
Elicio Therapeutics has raised a total of
$3.30M
in funding over 2 rounds. Their latest funding was raised on
Aug 3, 2012 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 3, 2012 | Series Unknown | $3.30M | 1 |
Access BridgeGap Ventures
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
9
0
Elicio Therapeutics has made 9 investments. Their most recent investment was on
Dec 10, 2019, when GOSU Data Lab raised $2.80M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 10, 2019
GOSU Data Lab
|
Series B | $2.80M | Analytics | — |
|
Jan 1, 2019
XREX Inc.
|
Seed | $7M | Bitcoin | — |
|
Aug 23, 2016
Coda Payments
|
Series A | $2M | Digital Entertainment | — |
|
Dec 2, 2013
Coda Payments
|
Series A | $2.30M | Digital Entertainment | — |
|
Jul 17, 2013
RedMart
|
Series A | — | E-Commerce | — |
Investors
Number of Lead Investors
Number of Investors
1
1
Elicio Therapeutics is funded by 1 investors.
Access BridgeGap Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Access BridgeGap Ventures
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
